✦ LIBER ✦

Tobramycin inhalation powder manufactured by improved process in cystic fibrosis: the randomized EDIT trial

✍ Scribed by Galeva, Ivanka; Konstan, Michael W.; Higgins, Mark; Angyalosi, Gerhild; Brockhaus, Florian; Piggott, Simon; Thomas, Karen; Chuchalin, Alexander G.

Book ID: 120431691
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 287 KB
Volume: 29
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007995.2013.805122

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

67 Trends in health-related quality of l

67 Trends in health-related quality of life (HRQoL) in cystic fibrosis with tobramycin inhalation powder: the EDIT trial

✍ A.L. Quittner; M. Higgins; G. Angyalosi; F. Brockhaus; K. Thomas; J. Zhang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

WS5.6 A challenging double-blind, placeb

WS5.6 A challenging double-blind, placebo-controlled study of tobramycin inhalation powder in cystic fibrosis: results of the EDIT trial

✍ I. Galeva; M.W. Konstan; M. Higgins; S. Piggott; G. Angyalosi; F. Brockhaus; K. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Safety, efficacy and convenience of tobr

Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial

✍ Michael W. Konstan; Patrick A. Flume; Matthias Kappler; Raphaël Chiron; Mark Hig 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 290 KB

86* Lung function improvement with aztre

86* Lung function improvement with aztreonam 75 mg powder and solvent for nebuliser solution (AZLI) in a single-arm extension of a randomized trial of inhaled antipseudomonal antibiotics in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa infection

✍ B.M. Assael; R. Chiron; R. Fischer; M. Bresnik; S. Lewis; A.B. Montgomery; T. Pr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB